Ranibizumab for retinal neovascularization

Ophthalmology. 2011 May;118(5):1004-1004.e1. doi: 10.1016/j.ophtha.2010.12.025.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Capillary Permeability
  • Female
  • Humans
  • Macula Lutea / pathology
  • Male
  • Middle Aged
  • Ranibizumab
  • Retinal Neovascularization / drug therapy*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*
  • Visual Acuity / physiology

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Ranibizumab